The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma Matthew W. ParsonsNicholas S. WhippleLindsay M. Burt Topic Review 31 October 2020 Pages: 93 - 101
A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care Ahmed HabibMatthew PeasePascal O. Zinn Topic Review 04 January 2021 Pages: 103 - 112
What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients? Anne ClavreulGhislaine AubinPhilippe Menei Laboratory Investigation 04 January 2021 Pages: 113 - 121
Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours Maria Antonietta OlivaSabrina StaffieriAntonietta Arcella Laboratory Investigation 04 January 2021 Pages: 123 - 133
Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide Isabella GomesDaniel Antunes MorenoRui Manuel Reis Laboratory Investigation 05 January 2021 Pages: 135 - 144
Predictors of long-term tumor control after stereotactic radiosurgery for Koos grade 4 vestibular schwannomas Toshinori HasegawaTakenori KatoYuuta Kouketsu Clinical Study 07 January 2021 Pages: 145 - 156
RETRACTED ARTICLE: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1 Lisha ChangJingyue WangJiang Zhang Clinical Study 30 October 2020 Pages: 157 - 171
Extent of resection and survival outcomes in World Health Organization grade II meningiomas Pranay SoniMark A. DavisonPablo F. Recinos Clinical Study 17 November 2020 Pages: 173 - 179
Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II–IV: a multicenter retrospective case series Vicki M. ButenschoenVanessa HubertusMaria Wostrack Clinical Study Open access 22 October 2020 Pages: 181 - 191
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma Alipi V. BonmAlec W. GibsonJerome J. Graber Clinical Study 04 January 2021 Pages: 193 - 200
Determinants and predictors for the long-term disease burden of intracranial meningioma patients Amir H. Zamanipoor NajafabadiPim B. van der Meeron behalf of the Dutch Meningioma Consortium Clinical Study Open access 19 October 2020 Pages: 201 - 210
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients Nadav SaridFelix BoksteinRon Ram Clinical Study 24 October 2020 Pages: 211 - 220
Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory Mitsutoshi NakadaRiho NakajimaMasashi Kinoshita Clinical Study 02 November 2020 Pages: 221 - 230
Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy Kevin Yijun FanNafisha LalaniAlan McVey Nichol Clinical Study 18 November 2020 Pages: 231 - 240
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases Rohan SavoorTimothy L. SitaSean Sachdev Clinical Study 11 November 2020 Pages: 241 - 247
Unexpected hubness: a proof-of-concept study of the human connectome using pagerank centrality and implications for intracerebral neurosurgery Jacky T. YeungHugh M. TaylorMichael E. Sughrue Clinical Study 10 November 2020 Pages: 249 - 256
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients Anna ChoHelena UntersteinerJosa M. Frischer Clinical Study Open access 11 November 2020 Pages: 257 - 265
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation Rachel W. ChanHanbo ChenAngus Z. Lau Clinical Study 16 November 2020 Pages: 267 - 278
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation L. PoetschC. BronnimannPOLA network Clinical Study 17 November 2020 Pages: 279 - 286
Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy Nupur BrahmbhattRoger StuppJessica W. Templer Clinical Study 04 January 2021 Pages: 287 - 293
Motor deficits at presentation and predictors of overall survival in central nervous system lymphomas Yu Tung LoYa Lyn Samantha AngLester Lee Clinical Study 04 January 2021 Pages: 295 - 306
Clear cell histology portends a worse prognosis than other WHO grade II histologies Pranay SoniJianning ShaoVarun R. Kshettry Clinical Study 04 January 2021 Pages: 307 - 312
Predictors of postoperative biochemical remission in acromegaly Shun YaoWen-Li ChenHai-Jun Wang Clinical Study 04 January 2021 Pages: 313 - 324
Stereotactic radiosurgery training patterns across neurosurgical programs: a multi-national survey Nardin SamuelDaniel M. TrifilettiJason Sheehan Clinical Study 04 January 2021 Pages: 325 - 330
Cyproterone acetate and meningioma: a nationwide-wide population based study Charles Champeaux-DepondJoconde WellerAgnes Sartor Clinical Study 04 January 2021 Pages: 331 - 338
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice Wenyin ShiDeborah T. BlumenthalMartin Glas Correction Open access 04 January 2021 Pages: 339 - 339